165 related articles for article (PubMed ID: 24924145)
21. Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use.
van der Wal HH; Grote Beverborg N; Dickstein K; Anker SD; Lang CC; Ng LL; van Veldhuisen DJ; Voors AA; van der Meer P
Eur Heart J; 2019 Nov; 40(44):3616-3625. PubMed ID: 31556953
[TBL] [Abstract][Full Text] [Related]
22. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study.
González-Costello J; Comín-Colet J; Lupón J; Enjuanes C; de Antonio M; Fuentes L; Moliner-Borja P; Farré N; Zamora E; Manito N; Pujol R; Bayés-Genis A
BMC Cardiovasc Disord; 2018 Nov; 18(1):206. PubMed ID: 30382817
[TBL] [Abstract][Full Text] [Related]
23. Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.
Tziakas DN; Chalikias GK; Stakos D; Chatzikyriakou SV; Papazoglou D; Mitrousi K; Lantzouraki A; Thomaidi A; Boudoulas H; Konstantinides S
Eur J Prev Cardiol; 2012 Feb; 19(1):62-71. PubMed ID: 20479644
[TBL] [Abstract][Full Text] [Related]
24. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.
Okonko DO; Mandal AK; Missouris CG; Poole-Wilson PA
J Am Coll Cardiol; 2011 Sep; 58(12):1241-51. PubMed ID: 21903058
[TBL] [Abstract][Full Text] [Related]
25. Soluble TNFα receptor type I and hepcidin as determinants of development of anemia in the long-term follow-up of heart failure patients.
Martínez-Ruiz A; Tornel-Osorio PL; Sánchez-Más J; Pérez-Fornieles J; Vílchez JA; Martínez-Hernández P; Pascual-Figal DA
Clin Biochem; 2012 Nov; 45(16-17):1455-8. PubMed ID: 22609894
[TBL] [Abstract][Full Text] [Related]
26. Are hematinic deficiencies the cause of anemia in chronic heart failure?
Witte KK; Desilva R; Chattopadhyay S; Ghosh J; Cleland JG; Clark AL
Am Heart J; 2004 May; 147(5):924-30. PubMed ID: 15131553
[TBL] [Abstract][Full Text] [Related]
27. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
28. Impact of iron deficiency on long-term clinical outcomes of hospitalized patients with heart failure.
Nakano H; Nagai T; Sundaram V; Nakai M; Nishimura K; Honda Y; Honda S; Iwakami N; Sugano Y; Asaumi Y; Aiba T; Noguchi T; Kusano K; Yokoyama H; Ogawa H; Yasuda S; Chikamori T; Anzai T;
Int J Cardiol; 2018 Jun; 261():114-118. PubMed ID: 29580659
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of reduced kidney function and anemia in patients with chronic heart failure.
Petretta M; Scopacasa F; Fontanella L; Carlomagno A; Baldissara M; de Simone A; Petretta MP; Bonaduce D
J Cardiovasc Med (Hagerstown); 2007 Nov; 8(11):909-16. PubMed ID: 17906476
[TBL] [Abstract][Full Text] [Related]
30. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of indeterminable anaerobic threshold in heart failure.
Agostoni P; Corrà U; Cattadori G; Veglia F; Battaia E; La Gioia R; Scardovi AB; Emdin M; Metra M; Sinagra G; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Cicoira M; Salvioni E; Giovannardi M; Mezzani A; Scrutinio D; Di Lenarda A; Mantegazza V; Ricci R; Apostolo A; Iorio A; Paolillo S; Palermo P; Contini M; Vassanelli C; Passino C; Piepoli MF;
Circ Heart Fail; 2013 Sep; 6(5):977-87. PubMed ID: 23881847
[TBL] [Abstract][Full Text] [Related]
32. Iron deficiency, anemia, and mortality in renal transplant recipients.
Eisenga MF; Minović I; Berger SP; Kootstra-Ros JE; van den Berg E; Riphagen IJ; Navis G; van der Meer P; Bakker SJ; Gaillard CA
Transpl Int; 2016 Nov; 29(11):1176-1183. PubMed ID: 27516242
[TBL] [Abstract][Full Text] [Related]
33. Anemia in patients with heart failure and preserved systolic function.
Felker GM; Shaw LK; Stough WG; O'Connor CM
Am Heart J; 2006 Feb; 151(2):457-62. PubMed ID: 16442914
[TBL] [Abstract][Full Text] [Related]
34. B-type natriuretic peptide. Guided vs. conventional care in outpatients with chronic heart failure: a retrospective study.
De Vecchis R; Esposito C; Di Biase G; Ariano C
Minerva Cardioangiol; 2013 Aug; 61(4):437-49. PubMed ID: 23846010
[TBL] [Abstract][Full Text] [Related]
35. β-blockers modify the prognostic value of adiponectin in chronic heart failure.
Van Berendoncks AM; Beckers P; Hoymans VY; Possemiers N; Coenen S; Elseviers MM; Vrints CJ; Conraads VM
Int J Cardiol; 2011 Aug; 150(3):296-300. PubMed ID: 20488568
[TBL] [Abstract][Full Text] [Related]
36. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
37. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction.
Akiyama E; Sugiyama S; Matsuzawa Y; Konishi M; Suzuki H; Nozaki T; Ohba K; Matsubara J; Maeda H; Horibata Y; Sakamoto K; Sugamura K; Yamamuro M; Sumida H; Kaikita K; Iwashita S; Matsui K; Kimura K; Umemura S; Ogawa H
J Am Coll Cardiol; 2012 Oct; 60(18):1778-86. PubMed ID: 23040568
[TBL] [Abstract][Full Text] [Related]
38. Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure.
Fröhlich GM; Keller P; Schmid F; Wolfrum M; Osranek M; Falk C; Noll G; Enseleit F; Reinthaler M; Meier P; Lüscher TF; Ruschitzka F; Tanner FC
Eur Heart J; 2013 May; 34(19):1414-23. PubMed ID: 23355650
[TBL] [Abstract][Full Text] [Related]
39. The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences.
Klip IT; Jankowska EA; Enjuanes C; Voors AA; Banasiak W; Bruguera J; Rozentryt P; Polonski L; van Veldhuisen DJ; Ponikowski P; Comin-Colet J; van der Meer P
Eur J Heart Fail; 2014 Jun; 16(6):655-62. PubMed ID: 24644024
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
